Datopotamab

Tax included
Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA topoisomerase I inhibitor Deruxtecan (HY-13631E) and Datopotamab.
MedChemExpress 
HY-P99843

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody
Application
Cancer-programmed cell death
CAS
2267989-53-5